Website stats for Gilenya - gilenya.com
Important Safety Information You should not take GILENYA if in the last months you experienced heart attack, unstable angina, stroke or mini-stroke (transient ischemic attack or TIA), or certain types of heart failure. Do not take GILENYA if you have an irregular or abnormal heartbeat (arrhythmia), including a heart finding called prolonged QT as seen on an ECG, or if you take medicines ...
gilenya.com was registered 1 decade 4 years ago. It has a alexa rank of #8,666,166 in the world. It is a domain having .com extension. It is estimated worth of $ 240.00 and have a daily income of around $ 1.00. As no active threats were reported recently, gilenya.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 101 |
| Daily Pageviews: | 202 |
Estimated Valuation
| Income Per Day: | $ 1.00 |
| Estimated Worth: | $ 240.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 8,666,166 |
| PageSpeed Score: | 89 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
45.60.131.251
Hosted Country:
US
Location Latitude:
39.6172Location Longitude:
-104.951Traffic Classification
| Total Traffic: | No Data |
| Direct Traffic: | No Data |
| Referral Traffic: | No Data |
| Search Traffic: | No Data |
| Social Traffic: | No Data |
| Mail Traffic: | No Data |
| Display Traffic: | No Data |
Search Engine Results For gilenya.com
Pill for RRMS Treatment | GILENYA® (fingolimod)
GILENYA is a once daily oral pill used to treat relapsing forms of multiple sclerosis (MS) in patients as young as 10. See full prescribing and safety info.
GILENYA® (fingolimod) | HCP - Relapsing-Remitting MS ...
Learn why HCPs are choosing GILENYA as a treatment for pediatric & adult patients with relapsing-remitting multiple sclerosis. See full prescribing & safety info.
Gilenya: Uses, Dosage & Side Effects - Drugs.com
Feb 03, 2020 · Gilenya and Tecfidera are both disease-modifying oral medications approved for the treatment of MS. Both are equally effective although Tecfidera is more likely...
Gilenya | National Multiple Sclerosis Society
Gilenya® is a new class of medication called a sphingosine 1-phosphate receptor modulator, which is thought to act by retaining certain white blood cells (lymphocytes) in the...
GILENYA Co-Pay & Savings Information | GILENYA® (fingolimod)
Once you're prescribed GILENYA, the GILENYA Go Program will call you to discuss your insurance coverage, check your eligibility for our co-pay support programs, and make your...
GILENYA® (fingolimod) | HCP - Relapsing-Remitting MS ...
Baseline QTc interval ≥500 msec. Cardiac arrhythmias requiring treatment with Class Ia or Class III anti-arrhythmic drugs. Patients who have had a hypersensitivity reaction to...
Co-Pay-gilenya
Indication. GILENYA is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease,...
GILENYA (fingolimod) Start Form and PrescriptionsFax 1-877 ...
FOR OFFICE USE ONLY GILENYA® (fingolimod) Start Form and PrescriptionsFax1-877-428-5889 Phone1-800-GILENYA (1-800-445-3692) Please complete all fields indicated to prevent any...
Gilenya Oral : Uses, Side Effects, Interactions, Pictures ...
How to use Gilenya. Read the Medication Guide provided by your pharmacist before you start taking fingolimod and each time you get a refill. If you have any questions, ask your...
Gilenya Side Effects: Common, Severe, Long Term - Drugs.com
Feb 09, 2020 · Note: This document contains side effect information about fingolimod. Some of the dosage forms listed on this page may not apply to the brand name Gilenya.. In...
What to expect with first dose of Gilenya
After failing my regular neuro checkup for the first time in years, my doctor decided to change my disease modifying therapy to Gilenya, feeling it was the best, most reliable...
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
First 6-Hour Monitoring Administer the first dose of GILENYA in a setting in which resources to appropriately managesymptomatic bradycardia are available.Monitorall patients for...
MEDICATION GUIDE GILENYA (je-LEN-yah) (fingolimod) …
MEDICATION GUIDE GILENYA® (je-LEN-yah) (fingolimod) capsules Read this Medication Guide before you start taking GILENYA and each time you get a refill. There may be new
Official Patient Website | Tecfidera® (dimethyl fumarate)
Laura S., living with relapsing MS. TECFIDERA ® (dimethyl fumarate) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically...
TYSABRI® (natalizumab) | Official Patient Website
What is TYSABRI? TYSABRI is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting...
Gilenya (Fingolimod Capsules): Uses, Dosage, Side Effects ...
What Is Gilenya? Gilenya (fingolimod) is a sphingosine 1-phosphate receptor modulator used to treat patients with relapsing forms of multiple sclerosis (MS) to reduce the...
Gilenya (fingolimod) - Sunray Drugs Specialty Pharmacy
Jun 08, 2020 · Gilenya is a medication used to treat relapsing multiple sclerosis. Gilenya is a once-a-day capsule that has shown to slowed disability progression, cut...
Prescription Assistance Programs | MSAA
Website: www.gilenya.com. Gilenya’s Patient Services Program will conduct a benefits investigation and determine on an individual basis what assistance a person may be eligible...
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | Not Applicable | H2 Headings: | 3 |
| H3 Headings: | Not Applicable | H4 Headings: | Not Applicable |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | 2 | Total Images: | 28 |
| Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Two Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| if you | 22 | 1.106 % | No |
| your doctor | 19 | 0.955 % | No |
| you have | 14 | 0.704 % | No |
| taking GILENYA | 9 | 0.452 % | No |
| Call your | 8 | 0.402 % | No |
| right away | 8 | 0.402 % | No |
| in the | 7 | 0.352 % | No |
| 2 months | 7 | 0.352 % | No |
| months after | 7 | 0.352 % | No |
| take GILENYA | 7 | 0.352 % | No |
| doctor right | 7 | 0.352 % | No |
| in your | 7 | 0.352 % | No |
| not take | 6 | 0.302 % | No |
| away if | 6 | 0.302 % | No |
| after stopping | 6 | 0.302 % | No |
| of the | 6 | 0.302 % | No |
| GILENYA if | 6 | 0.302 % | No |
| or if | 6 | 0.302 % | No |
| become pregnant | 5 | 0.251 % | No |
| changes in | 5 | 0.251 % | No |
Four Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| your doctor right away | 7 | 0.352 % | No |
| doctor right away if | 6 | 0.302 % | No |
| Call your doctor right | 6 | 0.302 % | No |
| not take GILENYA if | 6 | 0.302 % | No |
| your doctor if you | 5 | 0.251 % | No |
| right away if you | 5 | 0.251 % | No |
| away if you have | 4 | 0.201 % | No |
| Do not take GILENYA | 4 | 0.201 % | No |
| take GILENYA if you | 4 | 0.201 % | No |
| multiple sclerosis MS to | 3 | 0.151 % | No |
| of multiple sclerosis MS | 3 | 0.151 % | No |
| forms of multiple sclerosis | 3 | 0.151 % | No |
| disease and active secondary | 3 | 0.151 % | No |
| sclerosis MS to include | 3 | 0.151 % | No |
| include clinically isolated syndrome | 3 | 0.151 % | No |
| syndrome relapsingremitting disease and | 3 | 0.151 % | No |
| relapsingremitting disease and active | 3 | 0.151 % | No |
| isolated syndrome relapsingremitting disease | 3 | 0.151 % | No |
| relapsing forms of multiple | 3 | 0.151 % | No |
| to include clinically isolated | 3 | 0.151 % | No |
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Date: Sun, 10 Jan 2021 23:49:31 GMT
X-Frame-Options: SAMEORIGIN
X-XSS-Protection: 1; mode=block
X-Content-Type-Options: nosniff
Content-Type: text/html; charset=ISO-8859-1
Strict-Transport-Security: max-age=63072000; includeSubdomains; preload
Content-Language: en-US
Vary: User-Agent
Transfer-Encoding: chunked
X-CDN: Incapsula
Content-Encoding: gzip
X-Iinfo: 14-128253954-128254053 NNYY CT(0 0 0) RT(1610322570921 376) q(0 0 0 0) r(2 2) U12
Domain Information
| Domain Registrar: |
MarkMonitor Inc.
|
|---|---|
| Registration Date: | 2010-05-28 1 decade 4 years 5 months ago |
| Last Modified: | 2020-04-26 4 years 6 months 4 weeks ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| dns1.novartis.com | |
160.62.4.7 |  Switzerland |
| dns2.novartis.com | |
160.62.7.59 | Switzerland |
| dns3.novartis.com | |
160.62.14.115 | Switzerland |
| dns4.novartis.com | |
160.62.14.116 | Switzerland |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| gilenya.com | A | 86279 |
IP: 45.60.131.251 |
| gilenya.com | A | 86279 |
IP: 45.60.121.251 |
| gilenya.com | NS | 86400 |
Target: dns4.novartis.com |
| gilenya.com | NS | 86400 |
Target: dns3.novartis.com |
| gilenya.com | NS | 86400 |
Target: dns1.novartis.com |
| gilenya.com | NS | 86400 |
Target: dns2.novartis.com |
| gilenya.com | SOA | 86400 |
MNAME: dns1.novartis.com RNAME: hostmaster.novartis.com Serial: 2020111801 Refresh: 86400 Retry: 3600 Expire: 2592000 |
| gilenya.com | TXT | 86400 |
TXT: _globalsign-domain-verification=7sds8V_y xJs85tGBzTrGJBW_-FnpvcQ_6INfh5MCna |
| gilenya.com | TXT | 86400 |
TXT: ec3f8fc8-0cd4-48e0-bdc0-a40eb3147e23 |
| gilenya.com | TXT | 86400 |
TXT: _globalsign-domain-verification=uUOr1dzC 48XJHJPDgEJd1QwM5kdkah5N4YXHRaDF8R |
Full WHOIS Lookup
Registry Domain ID:
1599481793_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.markmonitor.com
Registrar URL:
http://www.markmonitor.com
Updated Date:
2020-04-26T09:05:24Z
Creation Date:
2010-05-28T07:48:18Z
Registry Expiry Date:
2022-05-28T07:48:18Z
Registrar: MarkMonitor Inc.
Registrar
IANA ID: 292
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
+1.2083895740
Domain Status: clientDeleteProhibited
https://icann.org/epp#clientDeleteProhibited
Domain Status:
clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Domain Status:
clientUpdateProhibited
https://icann.org/epp#clientUpdateProhibited
Domain Status:
serverDeleteProhibited
https://icann.org/epp#serverDeleteProhibited
Domain Status:
serverTransferProhibited
https://icann.org/epp#serverTransferProhibited
Domain Status:
serverUpdateProhibited
https://icann.org/epp#serverUpdateProhibited
Name Server:
DNS1.NOVARTIS.COM
Name Server: DNS2.NOVARTIS.COM
Name Server:
DNS3.NOVARTIS.COM
Name Server: DNS4.NOVARTIS.COM
DNSSEC:
unsigned
URL of the ICANN Whois Inaccuracy Complaint Form:
https://www.icann.org/wicf/
>>> Last update of whois database:
2021-01-10T23:51:00Z
Similarly Ranked Websites
Homepage - FB Reader
Free site FB Reader for searching and downloading all formates free ebooks for any gadgets. Exciting ebooks of all genres and authors are waiting for you!
8,666,217 
$ 240.00
I viaggi più belli del mondo. Luoghi da visitare foto, mappe e...
I posti più belli del mondo: Australia, Brasile, Grecia, Stati Uniti, Europa, Africa, America latina. Dal mare alla montagna tante foto, video, notizie e suggerimenti utili.
8,666,292 $ 240.00
Buffalo Area Teacher Recruitment Days - April 10, 2019
Visit the Buffalo Area Teacher Recruitment Days website, a premier teacher recruiting event in Western New York
8,666,308 $ 240.00